PREVENTION AND TREATMENT OF PNEUMOCYSTIS-CARINII PNEUMONIA

被引：0
|
作者：
HUGHES, WT [1 ]
机构：
[1] UNIV TENNESSEE, CTR HLTH SCI, DEPT PEDIAT, MEMPHIS, TN 38163 USA
来源：
ANNUAL REVIEW OF MEDICINE | 1991年 / 42卷
关键词：
IMMUNOCOMPROMISED HOST; TRIMETHOPRIM-SULFAMETHOXAZOLE; PENTAMIDINE; ACQUIRED IMMUNODEFICIENCY SYNDROME; TRIMETHOPRIM-SULFAMETHOXAZOLE; SYNDROME AIDS; CHEMOPROPHYLAXIS; PENTAMIDINE; DAPSONE; EFFICACY; THERAPY; DRUGS;
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
Several drugs are now available for the treatment and prevention of Pneumocystis carinii pneumonia. These include trimethoprim-sulfamethoxazole and pentamidine isethionate as first-line drugs and dapsone-trimethoprim, trimetrexate, piritrexim, fansidar, difluoromethylornithine, and clindamycin plus primaquine as drugs in later stages of clinical development. A hydroxynaphthoquinone, called 566C80, offers promise in preclinical studies. The use of corticosteroids in the supportive management of P. carinii pneumonitis is undergoing clinical study.
引用
收藏
页码：287 / 295
页数：9
相关论文
共 50 条
12345